Daehoon Kim Selected Research

Balanced Anesthesia

4/2022	Corrigendum: Effect-site concentration of remifentanil for preventing propofol injection pain during induction of balanced anesthesia.
4/2020	Effect-site concentration of remifentanil for preventing propofol injection pain during induction of balanced anesthesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daehoon Kim Research Topics

Disease

17	Atrial Fibrillation 07/2022 - 09/2017
6	Stroke (Strokes) 01/2022 - 11/2017
5	Dementia (Dementias) 01/2022 - 01/2020
4	Ischemic Stroke 01/2022 - 11/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 02/2016
3	Hemorrhage 01/2022 - 10/2018
2	Pain (Aches) 04/2022 - 04/2020
2	Vascular Diseases (Vascular Disease) 01/2021 - 11/2017
2	Heart Failure 01/2021 - 11/2017
2	Myocardial Infarction 08/2020 - 01/2020
2	Embolism (Embolus) 01/2020 - 10/2018
2	Transient Ischemic Attack 01/2018 - 11/2017
2	Neoplasms (Cancer) 01/2017 - 11/2016
1	COVID-19 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2022
1	Pathologic Constriction (Stenosis) 09/2021
1	Cardiac Arrhythmias (Arrythmia) 04/2021
1	Frailty 01/2021
1	Peptic Esophagitis (Reflux Esophagitis) 01/2021
1	Insulin Resistance 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2020
1	Coronary Occlusion 08/2020
1	Death (Near-Death Experience) 08/2020
1	Thrombosis (Thrombus) 08/2020
1	Hypertension (High Blood Pressure) 11/2017
1	Diabetes Mellitus 11/2017
1	Prehypertension 09/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Carcinogenesis 11/2016
1	Endocarditis 07/2016
1	Infections 07/2016
1	Prostatic Neoplasms (Prostate Cancer) 07/2010
1	Adenocarcinoma 07/2010
1	Breast Neoplasms (Breast Cancer) 07/2010

Drug/Important Bio-Agent (IBA)

5	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 10/2018
4	AnticoagulantsIBA 04/2021 - 11/2017
3	Vitamin K FDA Link 04/2021 - 01/2020
2	Remifentanil (Ultiva)FDA Link 04/2022 - 04/2020
2	Propofol (Diprivan)FDA LinkGeneric 04/2022 - 04/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2016
2	N(4)-oleylcytosine arabinosideIBA 01/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 09/2017 - 02/2016
1	Anti-Arrhythmia AgentsIBA 11/2021
1	A-factor (Streptomyces)IBA 04/2021
1	RivaroxabanIBA 01/2021
1	ORALIT (ORS)IBA 01/2021
1	apixabanIBA 01/2021
1	Dabigatran FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	omega-Chloroacetophenone (Mace)IBA 08/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	CreatinineIBA 10/2018
1	edoxabanIBA 10/2018
1	Factor Xa InhibitorsIBA 10/2018
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	ThiazidesIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2018
1	Hypnotics and Sedatives (Sedatives)IBA 01/2018
1	ribosomal protein S3IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 09/2017
1	IgA receptor (protein B)IBA 01/2017
1	Secretory Phospholipases A2IBA 01/2017
1	Surface-Active Agents (Surfactants)IBA 01/2017
1	Arachidonic Acid (Vitamin F)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 11/2016
1	Transforming Growth Factor-beta Type I ReceptorIBA 11/2016
1	Transcription Factors (Transcription Factor)IBA 11/2016
1	Phosphotransferases (Kinase)IBA 11/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2016
1	coactivator-associated arginine methyltransferase 1IBA 07/2010

Therapy/Procedure

9	Catheter Ablation 01/2022 - 12/2020
6	Therapeutics 07/2022 - 11/2017
2	Balanced Anesthesia 04/2022 - 04/2020
2	Stents 09/2021 - 08/2020
1	Electric Countershock (Cardioversion) 01/2022
1	Radiotherapy 01/2017
1	Transjugular Intrahepatic Portasystemic Shunt 07/2016